Infertility and implantation defects

Infertility and Reproductive Medicine Clinics of North America

Volumn 12, Issue 2, 2001, Pages 427-446

  Castelbaum, A J ^a   Lessey, B A ^a  

^a Northern Fertility and Reproductive Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN;

EMBRYO TRANSFER; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYDROSALPINX; INFERTILITY; INSULIN RESISTANCE; LUTEAL PHASE; NIDATION; OOCYTE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY; REVIEW;

EID: 0035073571     PISSN: 10479422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (154)

1. An increased number of replaced embryos counteracts the adverse effect of hydrosalpinges on IVF/ET outcome
2. Surgical treatment of endometriosis-associated infertility: Meta-analysis compared with survival analysis
3. The effect of peritoneal fluid from patients with endometriosis on human sperm function in vitro
4. Hydrosalpinx affects the implantation of previously cryopreserved embryos
5. Human embryo fragmentation in vitro and its implications for pregnancy and implantation
6. The infertile patient with hydrosalpinges-IVF with or without salpingectomy?
7. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography
8. Integrins β5, β3, αv are apically distributed in endometrial epithelium
9. The effect of endometriosis on implantation: Results from the Yale University in vitro fertilization and embryo transfer program
10. Hormonal profiles of natural conception cycles ending in early, unrecognized pregnancy loss
11. Luteal phase deficiency: An inadequate endometrial response to normal hormone stimulation
12. The endometrial biopsy for diagnosis of luteal phase deficiency
13. The endometrial biopsy for diagnosis of luteal phase deficiency
14. Dehydrogesterone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency
15. The effect of endometriosis on IVF outcome
16. Midluteal phase endometrial biopsy does not accurately predict luteal function
17. Hydrosalpingeal fluid inhibits in-vitro embryonic development in a murine model
18. Integrins and human reproduction
19. Some newer aspects of management of infertility
20. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: A meta-analysis of published comparative studies
21. Insights into the evaluation of the luteal phase
22. Corpus luteum defect - "Alloyed gold standard"
23. Clinical evaluation of the pipelle endometrial suction curette for timed endometrial biopsies
24. An informative protocol for the investigation of recurrent miscarriage: Preliminary experience of 500 consecutive cases
25. Hydrosalpinges adversely affect implantation in donor oocyte cycles
26. Induction of luteal phase defect with clomiphene citrate
27. Correlation of endometrial biopsy and plasma progesterone levels in infertile women
28. Implantation and development of mouse eggs transferred to the uterus of non-progestational mice
29. Integrin expression in normal and out-of-phase endometria
30. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine paracrine function in regulating embryo implantation
31. The late luteal phase in inferile women: Comparison of simultaneous endometrial biopsy and progesterone levels
32. The endometrium and the luteal phase defect
33. An analysis of endometrial biopsies performed for infertility
34. The incidence of luteal phase defect in normal, fertile women, determined by serial endometrial biopsies
35. Diagnostic test properties of serum progesterone in the evaluation of luteal phase defects
36. Only hydrosalpinges visible on ultrasound are associated with reduced implantation and pregnancy rates after in-vitro fertilization
37. Immunological aspects of endometriosis
38. Polycystic ovary syndrome: Anomalies in progesterone production
39. Cumulative conception rates following gonadotropin therapy
40. Expression of integrin messenger ribonucleic acid in human endometrium: A quantitative reverse transcription polymerase chain reaction study
41. The pregnancy rate of the no-treatment group in randomized clinical trials of endometriosis therapy
42. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer
43. Impaired implantation after in vitro fertilisation treatment associated with hydrosalpinx - Reply
44. Defective luteal function
45. The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects
46. Error in histologic dating of secretory endometrium: Variance component analysis
47. Genes associated with embryonic attachment and implantation and the role of progesterone
48. A quantitative evaluation of _1, _4, _V and _3 endometrial integrins of fertile and unexplained infertile women during the menstrual cycle. A flow cytometric appraisal
49. An endometrial factor in unexplained infertility
50. Is hydrosalpinx fluid cytotoxic?
51. Luteal phase deficiency after completely normal follicular and periovulatory phases
52. Regulation of Hoxa-10 and its expression in normal and abnormal endometrium
53. An evaluation of late luteal phase endometrium in women requesting reversal of tubal ligation
54. Experimental evidence for failure to implant as a mechanism of infertility associated with endometriosis
55. Clomiphene citrate therapy of infertile women with low luteal phase progesterone levels
56. Luteal insufficiency: Correlation between endometrial dating and integrated progesterone output in clomiphene citrate-induced cycles
57. A description of 34 human ova within the first 17 days of development
58. Polycystic ovary syndrome - From gynaecological curiosity to multisystem endocrinopathy
59. Gonadotropin releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovaries
60. Follicular phase treatment of luteal phase defect with follicle-stimulating hormone in infertile women
61. A quantitative overview of controlled trials in endometriosis-associated infertility
62. The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived from treated and untreated conception cycle
63. Effect of peritoneal fluid from women with endometriosis on implantation in the mouse model
64. Endometrial synthesis and secretion of complement component-3 by patients with and without endometriosis
65. Minimal endometriosis and reduced fecundability: Prospective evidence from an artificial insemination by donor program
66. Reduced pregnancy outcome in patients with unilateral or bilateral hydrosalpinx after in vitro fertilization
67. Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilization
68. Unexplained infertility: Defining the problem and understanding study design
69. Placental protein 14 in cycles with normal and retarded endometrial differentiation
70. The endometrial biopsy as a predictive factor of pregnancy rate in women with unexplained infertility
71. High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome
72. Embryo quality and endometrial receptivity: Lessons learned from the ART experience
73. Medical management of endometiosis and infertility
74. Defective endometrial receptivity: An under-appreciated cause of recurrent pregnancy loss
75. Further characterization of endometrial integrins during the menstrual cycle and in pregnancy
76. Use of integrins to date the endometrium
77. Effect of hydrosalpinges on markers of uterine receptivity and success in IVF
78. Aberrant integrin expression in the endometrium of women with endometriosis
79. Integrins as markers of uterine receptivity in women with primary unexplained infertility
80. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle
81. Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation
82. Endometrial development in the luteal phase of women with various types of infertility: Comparison with women of normal fertility
83. A comparison between two methods of chronological dating of human endometrial biopsies during the luteal phase and their correlation with histologic dating
84. Laparoscopic surgery in infertile women with minimal or mild endometriosis
85. Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium
86. Infertile women with and without endometriosis: A case control study of luteal phase and other infertility conditions
87. Hydrosalpinges adversely affect markers of endometrial receptivity
88. Effect of peritoneal fluid on in vitro cleavage of 2-cell mouse embryos: Possible role in infertility associated with endometriosis
89. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: A case for prophylactic salpingectomy
90. Oral clomiphene citrate and vaginal progesterone suppositories in the treatment of luteal phase dysfunction: A comparative study
91. The adverse effect of hydrosalpinges on in vitro fertilization pregnancy rates and the benefit of surgical correction
92. The presence of hydrosalpinx may not adversely affect the implantation and pregnancy rates in in vitron fertilization treatment
93. The underdeveloped secretory endometrium
94. Dating the endometrial biopsy
95. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function
96. Twenty-four-hour progesterone and luteinizing hormone profiles in the midluteal phase of the infertile patient: Correlation with other indicators of luteal phase insufficiency
97. Endometriosis: A stage by stage analysis - The role of in vitro fertilization
98. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium
99. Peritoneal fluid from women with moderate or severe endometriosis inhibits sperm motility: The role of seminal fluid components
100. Peritoneal fluid cytokines and the relationship with endometriosis and pain
101. Mild and moderate endometriosis. Comparison of treatment modalities for infertile couples
102. Endometrial receptivity and the luteal phase
103. Clinical evaluation of CA-125 concentrations as a prognostic factor for pregnancy in infertile women with surgically treated endometriosis
104. Uterine asynchrony: A cause of embryonic loss
105. Effect of human hydrosalpinx fluid on murine embryo development and implantation
106. The luteal phase defect: The relative frequency of, and encouraging response to, treatment with vaginal progesterone
107. Diagnosis of luteal phase inadequacy
108. A comparison of endometrial histology with simultaneous plasma progesterone determinations in infertile women
109. The use of transvaginal ultrasound to aspirate bilateral hydrosalpnges prior to in vitro fertilization: A case report
110. Detrimental effect of hydrosalpinx fluid on the development and blastulation of mouse embryos in vitro
111. Endometrial estradiol and progesterone receptors in patients with luteal phase defects and endometriosis
112. Hydrosalpinx fluid enhances human trophoblast viability and function in vitro: Implications for embryonic implantation in assisted reproduction
113. In vitro inhibition with antiestrogens of estradiol effects on prostaglandin F2 alpha production by human endometrium and endometrial epithelial cells
114. Surgically induction of endometriosis in the rabbit: Effects on fertility and concentration of peritoneal fluid prostaglandins
115. The effect of interobserver variation in dating endometrial histology on the diagnosis of luteal phase defects
116. Luteal phase defect: The possibility of an immunohistochemical diagnosis
117. Both midluteal serum progesterone levels and late luteal endometrial histology should be assessed in all infertile women
118. In-vitro fertilization outcome in women with hydrosalpinx
119. Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx
120. Comparison of serum progesterone and endometrial biopsy for confirmation of ovulation and evaluation of luteal function
121. Correlation of endometrial maturation with four methods of estimating day of ovulation
122. Luteal phase deficiency: Characterization of reproductive hormones over the menstrual cycle
123. Is the outcome of in-vitro fertilization and embryo transfer treatment improved by spontaneous or surgical drainage of a hydrosalpinx?
124. Amenorrhea associated with bilateral polycystic ovaries
125. Peritoneal fluid from endometriosis patients affects reproductive outcome in an in vivo model
126. Frequency of factors associated with habitual abortion in 197 couples
127. Preimplantation development of the mammalian embryo and its regulation by growth factors
128. Abnormal findings on hysterosalpingography: Effects on fecundity in a donor insemination program using frozen semen
129. Hydrosalpinx and IVF outcome: A prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF
130. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates
131. Endometriosis and infertility: A laparoscopic study of endometriosis among fertile and infertile women
132. Integrins and reproductive physiology: Expression and modulation in fertilization, embryogenesis, and implantation
133. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodeling
134. Dysregulated expression of ebaf, an occult and novel molecular defect in the endometria of patients with infertility
135. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis
136. HOX gene expression is altered in the endometrium of women with endometriosis
137. The importance of laparoscopic coagulation of mild endometriosis in infertile women
138. Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: Prospective study in 50 women
139. Ultrasound-guided aspiration of hydrosalpinges is associated with improved pregnancy and implantation rates after in-vitro fertilization cycles
140. Hydrosalpinges in in-vitro fertilization: An unfavourable prognostic feature
141. Prolactin in the evaluation of luteal phase in infertility
142. Incidence, symptoms, and signs of endometriosis in fertile and infertile women
143. Studies on the surgical induction of endometriosis in the rat
144. Outcome of progesterone treatment of luteal phase inadequacy
145. Endometrial biopsy in the evaluation of infertility
146. Time of implantation of the conceptus and loss of pregnancy
147. Endometrial receptivity in the light of modern assisted reproductive technologies
148. Histology of midluteal corpus luteum and endometrium from clomiphene citrate-induced cycles
149. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer